HURATOXIN
UNII GXV3CR7BC8

Substance Identification & Data

This profile provides standardized clinical and technical data for Huratoxin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GXV3CR7BC8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 33465-16-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GXV3CR7BC8

CAS Registry Number

33465-16-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

HURATOXIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C34H48O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VWGORPXMXKBHER-PAAMMUKASA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

6440991

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@H]1[C@@]23[C@@]([C@]4([C@](CO)(O4)[C@@H](O)[C@@]5(O)[C@]2(C=C(C)C5=O)[H])[H])([C@@]6([C@](C(C)=C)(C1)O[C@](/C=C/C=C/CCCCCCCCC)(O3)O6)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Huratoxin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

HIPPOMANE FACTOR M1

HURATOXIN

Systematic Nomenclature

(1R,2R,6S,7S,8R,10S,11S,12R,14S,16R,18R)-6,7-DIHYDROXY-8-(HYDROXYMETHYL)-4,18-DIMETHYL-16-(PROP-1-EN-2-YL)-14-((1E,3E)-TRIDECA-1,3-DIEN-1-YL)-9,13,15,19-TETRAOXAHEXACYCLO(12.4.1.0^(1,11).0^(2,6).0^(8,10).0^(12,16))NONADEC-3-EN-5-ONE

SYS

(2S-(2.ALPHA.(1E,3E),3A.BETA.,3B.BETA.,3C.BETA.,4A.BETA.,5.BETA.,5A.BETA.,8A.ALPHA.,8B.ALPHA.,9.ALPHA.,10A.BETA.))-3A,3B,3C,4A,5,5A,8A,9,10,10A-DECAHYDRO-5,5A-DIHYDROXY-4A-(HYDROXYMETHYL)-7,9-DIMETHYL-10A-(1-METHYLETHENYL)-2-(1,3-TRIDECADIENYL)-6H-2,8B-EPOXYOXIRENO(6,7)AZULENO(5,4-E)-1,3-BENZODIOXOL-6-ONE

SYS

(2S,3AR,3BS,3CS,4AR,5S,5AS,8AR,8BR,9R,10AR)-3A,3B,3C,4A,5,5A,8A,9,10,10A-DECAHYDRO-5,5A-DIHYDROXY-4A-(HYDROXYMETHYL)-7,9-DIMETHYL-10A-(1-METHYLETHENYL)-2-(1E,3E)-1,3-TRIDECADIEN-1-YL-6H-2,8B-EPOXYOXIRENO(6,7)AZULENO(5,4-E)-1,3-BENZODIOXOL-6-ONE

SYS

6H-2,8B-EPOXYOXIRENO(6,7)AZULENO(5,4-E)-1,3-BENZODIOXOL-6-ONE, 3A,3B,3C,4A,5,5A,8A,9,10,10A-DECAHYDRO-5,5A-DIHYDROXY-4A-(HYDROXYMETHYL)-7,9-DIMETHYL-10A-(1-METHYLETHENYL)-2-(1E,3E)-1,3-TRIDECADIEN-1-YL-, (2S,3AR,3BS,3CS,4AR,5S,5AS,8AR,8BR,9R,10AR)-

SYS

ORTHO-2,4-TETRADECADIENOIC ACID, CYCLIC 7,8,10A-ESTER WITH 5,6-EPOXY-4,5,6,6A,7,8,9,10,10A,10B-DECAHYDRO-3A,4,7,8,10A-PENTAHYDROXY-5-(HYDROXYMETHYL)-8-ISOPROPENYL-2,10-DIMETHYLBENZ(E)AZULEN-3(3AH)-ONE, (E,E)-(3AS,4S,5R,6S,6AS,7R,8R,10R,10AR,10BR)-(+)-

SYS

Technical Codes

NSC-266186

External Clinical & Regulatory Resources

Previous UNIIGXU9CK5AQH

Next UNIIGXV3QFL3VZ